A world-first treatment, developed in Perth, is showing promising results in protecting the brain after concussion.
The neuro-protective drug could limit the damage from a head knock, sparing patients from the life-changing effects of traumatic injury.
ARG-007 is a drug looking for a license to save lives.
“[It’s a] One shot wonder type of drug,” Dr Liz Dallimore told 9News.
The neuro-protective peptide, which is administered intravenously, is offering hope to those who suffer a concussion or other traumatic brain injuries.
It impacts an estimated 69 million people worldwide and is one of the leading causes of death and disability.
The latest pre-clinical trial at the University of Adelaide has shown positive results following testing on ferrets.
It was found to reduce brain damage and improving motor and memory function.
“Because it’s a really small peptide it can sneak into the brain and that means it can act on the neurons within the brain and protect them from the damage following a head injury,” Francis Corrigan, Associate Professor at the University of Adelaide told 9News.
Human trials for traumatic brain injury are set start next year, with ARG-007 to be rolled out at hospitals in Perth and nationally.
Results for a recent roll out on stroke patients in emergency departments across the country are expected next month.
“The hope for this drug [is that it] will be in every single ambulance in the world,” Dallimore said.
